New Targetable Oncogenes in Non–Small-Cell Lung Cancer
Geoffrey R. Oxnard(Boston Medical Center), Pasi A. Jänne(Dana-Farber Cancer Institute), Adam Binder(Beth Israel Deaconess Medical Center)
Cited by 298
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k